UnderDeveloped API’s : Anti-Diabetic
CAS NO. 29094-61-9
Therapeutic Class: Anti-Diabetic
Pharmacopoeia compliance: USP/BP
Glipizide is an oral rapid and short-acting anti-diabetic medication from the sulfonylurea class. It is classified as a second-generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas.